Patients Aren’t Adhering To Sovaldi As Much As They Should – CVS Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Real-world evidence on HCV combination therapy with Gilead’s sofosbuvir finds 8% of patients discontinued treatment short of the recommended regimen, a rate greater than seen in clinical trials and surprising in light of the drug’s effectiveness.